These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 197752)

  • 21. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro tests for the measurement of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture.
    Knight PA; Queminet J; Blanchard JH; Tilleray JH
    Biologicals; 1990 Oct; 18(4):263-70. PubMed ID: 2285500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of sheep against experimental Clostridium perfringens type A enteritis.
    Niilo L; Hauschild AH; Dorward WJ
    Can J Microbiol; 1971 Mar; 17(3):391-5. PubMed ID: 4323916
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development, preparation and safety testing of a Clostridium welchii type C toxoid. II. Laboratory evaluation of potency.
    Knight PA; Lucken RN; Foster W; Walker PD
    J Biol Stand; 1979; 7(4):373-81. PubMed ID: 231607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
    Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G
    J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
    Larina IA; Samsonova VS; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunochemical study of the enzymes of a toxic complex of Cl. perfringens].
    Ispolatovskaia MV; Klimacheva LV; Tokinova TN; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):89-93. PubMed ID: 4327165
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperimmunization of horses with alpha toxoid of Clostridium perfringens.
    Yanamoto A; Ito A; Murata R; Uematsu N; Nagai K
    Jpn J Med Sci Biol; 1970 Apr; 23(2):111-5. PubMed ID: 4318177
    [No Abstract]   [Full Text] [Related]  

  • 31. [Activity of anatoxins against infectious enterotoxemia of sheep, prepared with different adjuvants].
    Urguev KR; Ataev UI
    Veterinariia; 1977 Apr; (4):48-51. PubMed ID: 201079
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody formation in mice in various genotypes after immunization with highly purified perfringens alpha-toxoid.
    Petrov RV; Shemanova GF; Panteleyev EI; Dmitriyeva LN
    Arch Roum Pathol Exp Microbiol; 1976 Dec; 35(4):311-6. PubMed ID: 199137
    [No Abstract]   [Full Text] [Related]  

  • 33. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC
    Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The experimental validation of methods for the emergency immunoprophylaxis of gas gangrene].
    Sergeeva TI; Chirikova EV; Babaĭtseva VA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):9-13. PubMed ID: 8525744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of highly purified -toxoid of Clostridium perfringens.
    Sato H; Kameyama S; Murata R
    Jpn J Med Sci Biol; 1972 Feb; 25(1):53-6. PubMed ID: 4338981
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physico-chemical and immunobiological properties of the ribosomal preparations of Clostridium perfringens, type A].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):46-9. PubMed ID: 9662798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The International Reference Preparations of Clostridium welchii (C. perfringens) beta and epsilon toxoids.
    Davidson I; Gray AK; Hebert CN; Lesslie IW
    Bull World Health Organ; 1978; 56(4):641-8. PubMed ID: 215337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of
    Suzuki H; Hosomi K; Nasu A; Kondoh M; Kunisawa J
    Front Immunol; 2018; 9():2320. PubMed ID: 30356722
    [No Abstract]   [Full Text] [Related]  

  • 39. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
    Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with a nontoxic naturally occurring Clostridium perfringens alpha toxin induces neutralizing antibodies in rabbits.
    Siqueira FF; Silva ROS; do Carmo AO; de Oliveira-Mendes BBR; Horta CCR; Lobato FCF; Kalapothakis E
    Anaerobe; 2018 Feb; 49():48-52. PubMed ID: 29246841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.